Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Flower One is the largest cannabis cultivator, producer and full-service brand fulfillment partner in the state of Nevada. Flower One's fully operational flagship 400,000 square-foot greenhouse and 55,000 square-foot production facility is used for cannabis cultivation, processing, production and manufacturing of dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals and infused products. The Company also operates a 25,000 square-foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and a state of the art commercial kitchen that will produce several of the industry’s top performing edible brands. Leveraging its scale and more than 20 years of greenhouse operational excellence, Flower One offers consistent, reliable, high-volume, and just-in-time fulfillment to a growing number of established cannabis brands. The Company is fully licensed for both recreational and medical marijuana cultivation and production in the state of Nevada.

Flower One is the largest cannabis cultivator, producer and full-service brand fulfillment partner in the state of Nevada. Flower One's fully operational flagship 400,000 square-foot greenhouse and 55,000 square-foot production facility is used for cannabis cultivation, processing, production and manufacturing of dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals and infused products. The Company also operates a 25,000 square-foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and a state of the art commercial kitchen that will produce several of the industry’s top performing edible brands. Leveraging its scale and more than 20 years of greenhouse operational excellence, Flower One offers consistent, reliable, high-volume, and just-in-time fulfillment to a growing number of established cannabis brands. The Company is fully licensed for both recreational and medical marijuana cultivation and production in the state of Nevada.

FSD Pharma, Inc., is a publicly traded holding company since May 2018.

FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, FSD201, ultra-micronized palmitoylethanolamide (PEA). Ultra-micro PEA is known to target the CB2 receptors of the endocannabinoid system of the human body and acts by down-regulating the pro-inflammatory cytokines to effectuate an anti-inflammatory response.

The company has successfully completed Phase 1 first-in-human safety and tolerability study for FSD201 and has found the compound to be safe with no serious adverse side effects. This study also validated considerable scientific literature already published in the European Union that claims safety and tolerability of micro-PEA. Ultra-micro PEA is currently beings dispensed in Italy and Spain as a prescription based medical food supplement since 2004.

The company received permission from the Food and Drug Administration (FDA) on June 1, 2020 to submit an Investigational New Drug Application (IND) for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.

Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Company is focused on developing FSD201 for its anti-inflammatory properties to avoid the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.

 

Based in Sonoma County California, GABY Inc. is a cannabis consumer goods company with proprietary cannabis brands sold in over 200 dispensaries throughout California.  GABY owns a significant majority of its supply channel including, retail, manufacturing and  distribution.  GABY's strong asset base combined with a management team comprised of highly skilled and successful retail entrepreneurs along with pioneers in California cannabis establishes a strong foundation from which GABY will continue to aggressively grow its brand portfolio and dispensary footprint across California.

Gage Growth Corp. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm's founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage’s portfolio includes city and state approvals for multiple cultivation, processing and provisioning center (dispensaries) locations.

Investor Note: In addition to the 137,789,199 Subordinate Voting Shares that are listed and trading, there are 75,000,000 Subordinate Voting Shares reserved for issuance in connection with the redemption rights attached to Exchangeable Units outstanding. The total number of Subordinate Voting Shares, assuming the redemption of all Exchangeable Units outstanding, is 212,789,199.

Gaia Grow Corp. (the “Company”) is a licenced cultivator of industrial hemp. The Company’s business model leverages contract farming to utilize existing farmland and skilled farmers to cultivate industrial hemp, which it then sells to processors to be turned into hemp fibre and cannabidiol oil and concentrates. The Company expects to expand its operations to include retail cannabis stores in British Columbia.

Gemina Labs is a biosensor and diagnostic company with a unique and transformative proprietary biochemistry that significantly improves the performance of human and animal testings, including COVID-19, Influenza and other viruses.

Global Health Clinics operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. Through its pavilions, the company is developing a substantive consumer database of persons interested in both medicinal and recreational use

Vodis Pharmaceuticals Inc. is a craft cannabis producer in Delta, British Columbia, Canada.  The company was issued a Standard Cultivation licence and Standard Processing licence under the Cannabis Act on January 31, 2020.  The company operates a 12,000 sqft indoor facility growing proprietary cultivars for the adult-use, recreational cannabis market.  At full capacity, the Delta facility will yield approximately 1,500 kg of craft cannabis annually.  

Goodness Growth Holdings is one of America's leading multi-state cannabis companies. Goodness Growth Holdings is a physician-led, science-focused organization, dedicated to providing patients with best-in-class quality cannabis-based products and customer experience. Goodness Growth Holdings cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. Goodness Growth Holdings currently has licenses and/or operations in Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, and Puerto Rico.

In addition to the listed Subordinate Voting Shares, there are 414,949 Multiple Voting Shares and 65,411 Super Voting Shares issued and outstanding.  Each Super Voting Share is convertible into one Multiple Voting Share at the option of the holder or upon certain triggering events. Each Multiple Voting Share is convertible into 100 Subordinate Voting Shares at the option of the holder or upon certain triggering events. This number also includes subordinate voting shares underlying existing and proposed convertible securities.

 

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Richard_Carleton_Website.png

Business of Cannabis: New York

Wednesday, September 29, 2021 -
9:00am to 7:00pm
2021-09-20-Digital-Securities-in-the-Capital-Markets_Website.jpg

Digital Securities in the Capital Markets

Wednesday, October 6, 2021 -
2:00pm to 4:00pm

Advertisement

Publicité